Magnetic Resonance Imaging (MRI) in Predicting Response to Sunitinib Malate in Patients With Locally Advanced or Metastatic Kidney Cancer
Sponsors and Collaborators
Abramson Cancer Center of the University of Pennsylvania
Principal Investigator
Stephen Keefe, Abramson Cancer Center of the University of Pennsylvania
ClinicalTrials.gov Identifier
NCT01026337